TY - JOUR
T1 - Frequent mutation in the ABCC6 gene (R1141X) is associated with a strong increase in the prevalence of coronary artery disease
AU - Trip, Mieke D.
AU - Smulders, Yvo M.
AU - Wegman, Jurgen J.
AU - Hu, Xiaofeng
AU - Boer, Jolanda M. A.
AU - ten Brink, Jacoline B.
AU - Zwinderman, Aeilko H.
AU - Kastelein, John J. P.
AU - Feskens, Edith J. M.
AU - Bergen, Arthur A. B.
PY - 2002
Y1 - 2002
N2 - Background-Pseudoxanthoma elasticum (PXE) is an inborn disorder of the connective tissue with specific skin, ocular, and cardiovascular disease (CVD) manifestations. Recently, we and others have identified mutations in the gene coding for the ABCC6 transporter in PXE patients with ocular and skin involvement. In the Netherlands, as in the rest of Europe, a particular premature truncation variant ABCC6 (R1141X) was found in a large cohort of PXE patients. Given the association between CVD and PXE, we hypothesized that heterozygosity of this ABCC6 mutation could also confer an increased risk for CVD. Methods and Results-To assess. the relationship between the frequent R1141X mutation in the ABCC6 gene and the prevalence of premature coronary artery disease (CAD), we conducted a case-control study of 441 patients under the age of 50 years who h ad definite CAD and 1057 age- and sex-matched population-based controls who were free of coronary disease. Strikingly, the prevalence of the R1141X mutation was 4.2 times higher among patients than among controls (3.2% versus 0.8%; P <0.001). Consequently, among subjects with the R1141X mutation, the odds ratio for a coronary event was 4.23 (95% CI 1.76 to 10.20, P=0.001). Conclusion-The presence of the R1141X mutation in the ABCC6 gene is associated with a sharply increased risk of premature CAD
AB - Background-Pseudoxanthoma elasticum (PXE) is an inborn disorder of the connective tissue with specific skin, ocular, and cardiovascular disease (CVD) manifestations. Recently, we and others have identified mutations in the gene coding for the ABCC6 transporter in PXE patients with ocular and skin involvement. In the Netherlands, as in the rest of Europe, a particular premature truncation variant ABCC6 (R1141X) was found in a large cohort of PXE patients. Given the association between CVD and PXE, we hypothesized that heterozygosity of this ABCC6 mutation could also confer an increased risk for CVD. Methods and Results-To assess. the relationship between the frequent R1141X mutation in the ABCC6 gene and the prevalence of premature coronary artery disease (CAD), we conducted a case-control study of 441 patients under the age of 50 years who h ad definite CAD and 1057 age- and sex-matched population-based controls who were free of coronary disease. Strikingly, the prevalence of the R1141X mutation was 4.2 times higher among patients than among controls (3.2% versus 0.8%; P <0.001). Consequently, among subjects with the R1141X mutation, the odds ratio for a coronary event was 4.23 (95% CI 1.76 to 10.20, P=0.001). Conclusion-The presence of the R1141X mutation in the ABCC6 gene is associated with a sharply increased risk of premature CAD
U2 - https://doi.org/10.1161/01.CIR.0000028420.27813.C0
DO - https://doi.org/10.1161/01.CIR.0000028420.27813.C0
M3 - Article
C2 - 12176944
SN - 0009-7322
VL - 106
SP - 773
EP - 775
JO - Circulation
JF - Circulation
IS - 7
ER -